Veolia's Environmental Solutions and Services (ESS) waste management division is recognized as one of the largest and most sophisticated services of its kind in the U.S., providing comprehensive, safe, reliable handling of a full range of waste streams including complex medical waste disposal.
For 20 years, the ESS team has developed a model partnership with MassBio, an internationally recognized consortium of cutting-edge medical and biotech research firms that have made Massachusetts a "hub" of innovation in the biotech sector, including breakthroughs in developing COVID-19 vaccines.
Veolia has been instrumental in supporting these efforts by ensuring that the complex medical waste streams that result from biotech research are properly and safely managed. In the process, MassBio has come to rely on Veolia as a trusted partner, expanding the relationship to the point that Veolia recently completed construction of a state-of-the-art medical waste management facility in suburban Boston, which will enhance the company's capabilities for meeting the needs of MassBio members.
Check out this article in Waste Today spotlighting the successful partnership between Veolia and MassBio.